Moreover, PD-L2 exhibited significantly higher expression than PD-L1 in exosomes from both patient-derived primary tumor cells and different types of cancer patients, including ccRCC, colon, prostate, and lung adenocarcinoma (Figs. 1L and S1J). The gene discussed is PDCD1LG2; the disease is cancer.